In this pathway, the most common genetic abnormality is represented by activating mutations in Phosphatidylinositol-4-5-bisphosphate-3-kinase catalytic subunit-α (PIK3CA) gene, with a reported frequency of 20–40% in BC [15,16]. The gene discussed is PIK3CA; the disease is breast cancer.